Home ETF List About

Portfolio Holdings Detail for ISIN IE00BHZPJ890
Stock Name / FundiShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF TickerEEDG(GBP) LSE
ETF TickerEEDS(USD) LSE
ETF TickerEEDG.LS(GBP) CXE
ETF TickerEEDS.LS(USD) CXE
ETF TickerOM3L.DE(EUR) CXE
ETF TickerEEDG.L(GBP) LSE
ETF TickerEEDS.L(GBP) LSE

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist) LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-09-30 (Tuesday)364,923USD 278,436,249LLY holding increased by 13316040USD 278,436,2490USD 13,316,040 USD 763 USD 726.51
2025-09-29 (Monday)364,923LLY holding increased by 88USD 265,120,209LLY holding increased by 782658USD 265,120,20988USD 782,658 USD 726.51 USD 724.54
2025-09-26 (Friday)364,835LLY holding decreased by -4516USD 264,337,551LLY holding increased by 403020USD 264,337,551-4,516USD 403,020 USD 724.54 USD 714.59
2025-09-25 (Thursday)369,351LLY holding increased by 2410USD 263,934,531LLY holding decreased by -8280650USD 263,934,5312,410USD -8,280,650 USD 714.59 USD 741.85
2025-09-24 (Wednesday)366,941USD 272,215,181USD 272,215,181
2025-09-18 (Thursday)350,129LLY holding increased by 1232USD 267,123,918LLY holding increased by 1916841USD 267,123,9181,232USD 1,916,841 USD 762.93 USD 760.13
2025-09-17 (Wednesday)348,897LLY holding increased by 1978USD 265,207,077LLY holding decreased by -85351USD 265,207,0771,978USD -85,351 USD 760.13 USD 764.71
2025-09-16 (Tuesday)346,919USD 265,292,428LLY holding increased by 5731101USD 265,292,4280USD 5,731,101 USD 764.71 USD 748.19
2025-09-15 (Monday)346,919LLY holding increased by 980USD 259,561,327LLY holding decreased by -1757534USD 259,561,327980USD -1,757,534 USD 748.19 USD 755.39
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00BHZPJ890

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-29BUY88 726.510* 805.07
2025-09-26SELL-4,516 724.540* 805.51 Profit of 3,637,676 on sale
2025-09-25BUY2,410 714.590* 806.01
2025-09-18BUY1,232 762.930* 806.25
2025-09-17BUY1,978 760.130* 806.50
2025-09-15BUY980 748.190* 807.06
2025-09-12BUY748 755.390* 807.36
2025-09-11SELL-2,498 756.280* 807.65 Profit of 2,017,502 on sale
2025-09-10BUY454 754.620* 807.95
2025-09-09BUY598 750.610* 808.28
2025-08-27SELL-2,668 734.170* 808.71 Profit of 2,157,632 on sale
2025-08-21BUY90 709.820* 809.85
2025-08-19BUY276 703.210* 811.10
2025-07-21BUY47 762.180* 811.39
2025-07-18BUY2,125 771.710* 811.63
2025-07-17BUY1,635 761.500* 811.93
2025-07-16BUY4,088 789.800* 812.07
2025-07-15BUY2,530 771.750* 812.31
2025-07-03SELL-352 780.670* 812.70 Profit of 286,072 on sale
2025-07-02SELL-2,852 779.280* 812.91 Profit of 2,318,423 on sale
2025-06-30SELL-74 779.530* 813.12 Profit of 60,171 on sale
2025-06-27BUY184 775.450* 813.36
2025-06-26BUY94 795.120* 813.47
2025-06-25BUY184 792.300* 813.61
2025-06-24SELL-138 778.080* 813.83 Profit of 112,309 on sale
2025-06-17SELL-186 791.240* 814.99 Profit of 151,588 on sale
2025-06-13SELL-78 819.360* 815.01 Profit of 63,571 on sale
2025-06-12BUY132 812.030* 815.03
2025-06-06SELL-644 769.880* 815.73 Profit of 525,331 on sale
2025-06-05SELL-1,012 765.680* 816.08 Profit of 825,874 on sale
2025-06-04SELL-1,305 765.840* 816.43 Profit of 1,065,447 on sale
2025-06-03BUY270 750.780* 816.90
2025-06-02SELL-78 747.120* 817.40 Profit of 63,757 on sale
2025-05-30BUY14,911 737.670* 817.97
2025-05-29SELL-267 722.570* 818.66 Profit of 218,583 on sale
2025-05-28SELL-176 719.390* 819.39 Profit of 144,212 on sale
2025-05-23SELL-782 713.710* 821.67 Profit of 642,544 on sale
2025-05-22BUY43 715.200* 822.47
2025-05-21SELL-220 724.950* 823.21 Profit of 181,106 on sale
2025-05-20BUY946 747.010* 823.79
2025-05-16SELL-396 757.390* 824.84 Profit of 326,635 on sale
2025-05-15BUY46 733.290* 825.55
2025-05-14BUY778 715.560* 826.42
2025-05-13BUY2,839 746.060* 827.06
2025-05-12BUY2,279 755.570* 827.63
2025-05-09BUY731 734.570* 828.38
2025-05-08SELL-704 751.450* 829.00 Profit of 583,618 on sale
2025-05-07BUY2,021 776.720* 829.43
2025-05-06BUY473 775.120* 829.88
2025-05-02SELL-81 823.620* 830.00 Profit of 67,230 on sale
2025-05-01SELL-43 794.100* 830.31 Profit of 35,703 on sale
2025-04-29BUY1 885.200* 829.24
2025-04-28SELL-5,939 877.290* 828.83 Profit of 4,922,393 on sale
2025-04-25SELL-86 884.540* 828.34 Profit of 71,237 on sale
2025-04-24SELL-1,333 859.730* 828.06 Profit of 1,103,802 on sale
2025-04-23SELL-473 829.420* 828.05 Profit of 391,666 on sale
2025-04-22SELL-308 827.540* 828.05 Profit of 255,040 on sale
2025-04-16SELL-1,677 734.900* 828.79 Profit of 1,389,886 on sale
2025-04-11BUY838 732.410* 831.12
2025-04-10BUY264 720.910* 832.19
2025-04-09BUY435 753.710* 832.96
2025-04-08SELL-1,235 726.240* 834.02 Profit of 1,030,015 on sale
2025-04-07BUY831 723.730* 835.12
2025-04-04BUY1,833 738.210* 836.10
2025-04-02BUY739 818.220* 836.28
2025-04-01BUY352 805.230* 836.60
2025-03-31SELL-738 825.910* 836.72 Profit of 617,496 on sale
2025-03-28SELL-176 822.510* 836.87 Profit of 147,288 on sale
2025-03-26BUY44 826.760* 837.14
2025-03-25BUY132 852.350* 836.97
2025-03-24BUY264 864.900* 836.67
2025-03-21BUY6,776 837.570* 836.66
2025-03-20BUY88 842.570* 836.59
2025-03-19SELL-1,247 837.010* 836.58 Profit of 1,043,220 on sale
2025-03-17SELL-88 824.760* 836.89 Profit of 73,646 on sale
2025-03-14SELL-176 813.480* 837.16 Profit of 147,340 on sale
2025-03-13SELL-43 801.650* 837.58 Profit of 36,016 on sale
2025-03-12SELL-247 821.860* 837.77 Profit of 206,930 on sale
2025-03-11BUY44 824.060* 837.94
2025-03-06BUY2,666 912.760* 836.70
2025-03-05SELL-218 929.720* 835.50 Profit of 182,140 on sale
2025-03-03BUY132 929.720* 833.27
2025-02-28SELL-10,068 920.630* 832.10 Profit of 8,377,628 on sale
2025-02-27SELL-880 905.160* 831.12 Profit of 731,383 on sale
2025-02-26SELL-11,239 915.010* 829.97 Profit of 9,328,011 on sale
2025-02-25SELL-765 901.800* 828.97 Profit of 634,162 on sale
2025-02-24BUY1,100 881.400* 828.23
2025-02-21BUY574 873.680* 827.58
2025-02-20BUY105 873.120* 826.92
2025-02-19BUY90 867.050* 826.33
2025-02-18SELL-490 857.200* 825.87 Profit of 404,677 on sale
2025-02-14BUY135 844.270* 825.31
2025-02-13SELL-90 871.860* 824.58 Profit of 74,212 on sale
2025-02-12SELL-1,710 872.970* 823.81 Profit of 1,408,716 on sale
2025-02-10SELL-11 868.880* 822.40 Profit of 9,046 on sale
2025-02-06BUY238 870.370* 820.64
2025-02-05SELL-675 842.180* 820.26 Profit of 553,678 on sale
2025-02-03BUY80 810.430* 820.34
2025-01-30SELL-924 823.230* 820.45 Profit of 758,099 on sale
2025-01-29SELL-4 804.080* 820.76 Profit of 3,283 on sale
2025-01-28SELL-594 804.990* 821.07 Profit of 487,713 on sale
2025-01-27BUY270 808.170* 821.32
2025-01-24BUY484 785.410* 822.04
2025-01-23BUY484 766.600* 823.17
2024-12-09BUY90 803.580* 824.09
2024-12-06BUY1,395 826.710* 824.03
2024-12-04BUY1,035 829.840* 823.86
2024-12-03BUY603 813.330* 824.11
2024-12-02BUY1,350 799.800* 824.69
2024-11-29BUY135 795.350* 825.40
2024-11-27BUY45 788.190* 827.31
2024-11-26SELL-1,545 789.320* 829.36 Profit of 1,281,365 on sale
2024-11-26SELL-1,545 789.320* 829.36 Profit of 1,281,365 on sale
2024-11-25SELL-14,898 755.000* 833.61 Profit of 12,419,152 on sale
2024-11-25SELL-14,898 755.000* 833.61 Profit of 12,419,152 on sale
2024-11-22SELL-89 748.010* 836.13 Profit of 74,416 on sale
2024-11-21BUY2,022 749.920* 838.74
2024-11-19SELL-433 729.730* 845.01 Profit of 365,890 on sale
2024-11-18BUY959 727.200* 848.94
2024-11-12BUY48 818.860* 849.98
2024-11-08BUY142 831.540* 852.07
2024-11-08BUY142 831.540* 852.07
2024-11-07BUY3,619 797.450* 856.62
2024-11-07BUY3,619 797.450* 856.62
2024-11-06BUY96 776.380* 863.91
2024-11-06BUY96 776.380* 863.91
2024-11-05SELL-245 806.060* 869.70 Profit of 213,076 on sale
2024-11-05SELL-245 806.060* 869.70 Profit of 213,076 on sale
2024-11-04SELL-1,692 806.140* 876.76 Profit of 1,483,481 on sale
2024-11-04SELL-1,692 806.140* 876.76 Profit of 1,483,481 on sale
2024-11-01SELL-480 818.930* 883.99 Profit of 424,316 on sale
2024-11-01SELL-480 818.930* 883.99 Profit of 424,316 on sale
2024-10-31BUY270 829.740* 891.74
2024-10-31BUY270 829.740* 891.74
2024-10-30SELL-1,780 846.830* 899.23 Profit of 1,600,622 on sale
2024-10-30SELL-1,780 846.830* 899.23 Profit of 1,600,622 on sale
2024-10-29SELL-1,656 903.580* 898.83 Profit of 1,488,462 on sale
2024-10-28BUY138 895.590* 899.55
2024-10-28BUY138 895.590* 899.55
2024-10-25BUY3,008 892.700* 901.51
2024-10-25BUY3,008 892.700* 901.51
2024-10-24BUY364 891.320* 905.58
2024-10-24BUY364 891.320* 905.58
2024-10-23SELL-80 903.250* 907.14 Profit of 72,571 on sale
2024-10-23SELL-80 903.250* 907.14 Profit of 72,571 on sale
2024-10-22BUY322 909.150* 906.13
2024-10-21SELL-3,220 906.130* 0.00
2024-10-21SELL-3,220 906.130* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.